FR2191887A1 - 7-Substd 5-hydroxy-imidazo pyrimidines - antiinflammatories, and immuno-suppressives, from 2-aminoimidazoline and substd ethyl acetates - Google Patents
7-Substd 5-hydroxy-imidazo pyrimidines - antiinflammatories, and immuno-suppressives, from 2-aminoimidazoline and substd ethyl acetatesInfo
- Publication number
- FR2191887A1 FR2191887A1 FR7224618A FR7224618A FR2191887A1 FR 2191887 A1 FR2191887 A1 FR 2191887A1 FR 7224618 A FR7224618 A FR 7224618A FR 7224618 A FR7224618 A FR 7224618A FR 2191887 A1 FR2191887 A1 FR 2191887A1
- Authority
- FR
- France
- Prior art keywords
- substd
- aminoimidazoline
- antiinflammatories
- immuno
- imidazo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Novel imidazo 1,2-a pyrimidine derivs of formula (I) (where R1 is H, alkyl, benzyl or ethoxycarbonyl-alkyl, and R2 is >=3C alkyl, or alkenyl, cycloalkyl, carboxy, ethoxycarbonylalkyl, phenyl substd by halogen, alkyl, NO2, amino, alkoxy, benzoyloxy, OH or alkylsulphonyl, or R2 is heterocyclyl). are useful as antipyretics, antiinflammatories, antirheumatics and immuno-suppressive agents. They are prepd by reacting 2-aminoimidazoline with R2COCHR1COOC2H5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7224618A FR2191887A1 (en) | 1972-07-07 | 1972-07-07 | 7-Substd 5-hydroxy-imidazo pyrimidines - antiinflammatories, and immuno-suppressives, from 2-aminoimidazoline and substd ethyl acetates |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7224618A FR2191887A1 (en) | 1972-07-07 | 1972-07-07 | 7-Substd 5-hydroxy-imidazo pyrimidines - antiinflammatories, and immuno-suppressives, from 2-aminoimidazoline and substd ethyl acetates |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2191887A1 true FR2191887A1 (en) | 1974-02-08 |
FR2191887B1 FR2191887B1 (en) | 1975-08-08 |
Family
ID=9101514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7224618A Granted FR2191887A1 (en) | 1972-07-07 | 1972-07-07 | 7-Substd 5-hydroxy-imidazo pyrimidines - antiinflammatories, and immuno-suppressives, from 2-aminoimidazoline and substd ethyl acetates |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2191887A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6858602B2 (en) | 2001-06-12 | 2005-02-22 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2011970A1 (en) * | 1970-03-13 | 1971-11-18 | CH. Boehringer Sohn, 6507 Ingelheim | Imidazo-(1, 2-a)- pyrimidines prepn |
-
1972
- 1972-07-07 FR FR7224618A patent/FR2191887A1/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2011970A1 (en) * | 1970-03-13 | 1971-11-18 | CH. Boehringer Sohn, 6507 Ingelheim | Imidazo-(1, 2-a)- pyrimidines prepn |
Non-Patent Citations (1)
Title |
---|
BULLETIN DES SOCIETES CHIMIQUES BELGES 59, 573-87 1950 .) * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6858602B2 (en) | 2001-06-12 | 2005-02-22 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US6916848B2 (en) | 2001-06-12 | 2005-07-12 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US6924314B2 (en) | 2001-06-12 | 2005-08-02 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US6946491B2 (en) | 2001-06-12 | 2005-09-20 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US7012071B2 (en) | 2001-06-12 | 2006-03-14 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US7041659B2 (en) | 2001-06-12 | 2006-05-09 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US7045541B2 (en) | 2001-06-12 | 2006-05-16 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US7101910B2 (en) | 2001-06-12 | 2006-09-05 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US7329782B2 (en) | 2001-06-12 | 2008-02-12 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US7547802B2 (en) | 2001-06-12 | 2009-06-16 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US7863475B2 (en) | 2001-06-12 | 2011-01-04 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
US8487000B2 (en) | 2001-06-12 | 2013-07-16 | Wellstat Therapertics Corporation | Compound for the treatment of metabolic disorders |
US8552062B2 (en) | 2001-06-12 | 2013-10-08 | Wellstat Therapeutics Corporation | Methods for the treatment of metabolic disorders such as diabetes |
US8604083B2 (en) | 2001-06-12 | 2013-12-10 | Wellstat Therapeutics Corporation | Method for the treatment of metabolic disorders |
Also Published As
Publication number | Publication date |
---|---|
FR2191887B1 (en) | 1975-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9701048A2 (en) | Novel process for preparing sildenafil and new intermediates utilized therein | |
DK307289A (en) | pyrimidine | |
FR2191887A1 (en) | 7-Substd 5-hydroxy-imidazo pyrimidines - antiinflammatories, and immuno-suppressives, from 2-aminoimidazoline and substd ethyl acetates | |
ES442057A1 (en) | Novel penicillins and their preparation | |
JPS6442468A (en) | Substituted pyridylethanolamine, manufacture and use as livestock yield promoter | |
FI860074A0 (en) | OKTAHYDROINDOLIZINFOERENINGAR ANVAENDBARA SOM SMAERTSTILLANDE MEDEL. | |
GB1366283A (en) | 3-hydrazonomethyl rifamycin sv | |
IE40561B1 (en) | Alkylmercaptomethylquinoxaline 1,4-dioxides and derivatives thereof | |
ES434930A1 (en) | Benzazepinyl sulfonylureas and intermediates therefore | |
ES8801309A1 (en) | Acylated sugars, method for their preparation and their use. | |
ES424346A1 (en) | 5-Oxo-2,3-dihydro-imidazo(1,2-a)-s-triazines | |
ES8306161A1 (en) | Novel nitrosourea derivative, process for preparing same and therapeutic composition containing said derivate. | |
ES8505636A1 (en) | Substituted tropyl and pseudotropyl benzoates and their use in migraine treatment. | |
FR2178818A1 (en) | Phenylbutazone - aminoacid salts - anti-inflammatories and analgesics | |
US4010175A (en) | Thio-{62 -lactam penicillins | |
ES2004804A6 (en) | Carboxy-alkyl di:peptide deriv. prepn | |
ES462429A1 (en) | 1-Methyl-3-formyl-3-substituted ureas | |
AU552170B2 (en) | Sulphonyl ureas | |
NL7811882A (en) | 2-(ortho-aminophenethyl) piperidines - as antiarrhythmic, antiserotonin agents | |
BE746797A (en) | Imidazo (2,1-a) isoindoles useful as anorexige - nics and cns stimulants | |
GB1383465A (en) | Glucosamide of 1- p-chlorobenzoyl indolyl-3-acetic acid and processes for its preparation | |
GB1234635A (en) | ||
BE803210A (en) | Corynanthine hydrazides - as therapeutic agents | |
NL7402745A (en) | N-(2-carbamoylvinyl)aminoacids - N-protection of aminoacids by reaction with aminocarbonyl-acetone derivs | |
FR2206320A1 (en) | 4-Hydroxy, amino or mercapto-5-oxy-pyrazolo (3,4-d)-pyrimidines - xanth-ine oxydase inhibitors useful as anti-gout and uricosuric agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property | ||
CD | Change of name or company name | ||
TP | Transmission of property | ||
ST | Notification of lapse |